Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
ABSTRACT Research progress over the past 20 years has yielded several experimental Ebola virus (EBOV) vaccine candidates, which were shown to be effective in nonhuman primates when given 28 days before a lethal challenge. Of these, the vesicular stomatitis virus (VSV)-vectored vaccine against EBOV (...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2019-08-01
|
| シリーズ: | mBio |
| 主題: | |
| オンライン･アクセス: | https://journals.asm.org/doi/10.1128/mBio.01597-19 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|